Your browser doesn't support javascript.
loading
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.
Ritterhouse, Lauren L; Nowak, Jonathan A; Strickland, Kyle C; Garcia, Elizabeth P; Jia, Yonghui; Lindeman, Neal I; Macconaill, Laura E; Konstantinopoulos, Panagiotis A; Matulonis, Ursula A; Liu, Joyce; Berkowitz, Ross S; Nucci, Marisa R; Crum, Christopher P; Sholl, Lynette M; Howitt, Brooke E.
Afiliação
  • Ritterhouse LL; Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Nowak JA; Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Strickland KC; Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Garcia EP; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Jia Y; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Lindeman NI; Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Macconaill LE; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Konstantinopoulos PA; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Matulonis UA; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Liu J; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Berkowitz RS; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Nucci MR; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Crum CP; Women's and Perinatal Pathology Division, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Sholl LM; Women's and Perinatal Pathology Division, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Howitt BE; Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Mod Pathol ; 29(8): 893-903, 2016 08.
Article em En | MEDLINE | ID: mdl-27150160
Extrauterine high-grade serous carcinomas can exhibit various histologic patterns including (1) classic architecture that is papillary, micropapillary and infiltrative and (2) solid, endometrioid, and transitional (ie, SET) patterns. Although the SET pattern has been associated with germline BRCA mutations, potential molecular underpinnings have not been fully investigated. DNA was isolated from 174 carcinomas of the fallopian tube, ovary, or peritoneum. Targeted next-generation sequencing was performed and single-nucleotide and copy number variants were correlated with morphologic subtype. Overall, 79% of tumors were classified as high-grade serous carcinoma (n=138), and the most common mutations in high-grade serous carcinomas were TP53 (94%), BRCA1 (25%), BRCA2 (11%), and ATM (7%). Among chemotherapy-naive high-grade serous carcinomas, 40 cases exhibited classic morphology and 40 cases had non-classic morphology (SET or ambiguous features). Mutations in homologous recombination pathways were seen across all tumor histotypes. High-grade serous carcinomas with homologous recombination mutations were six times more likely to be associated with non-classic histology (P=0.002) and were significantly more likely to be platinum sensitive and have improved progression-free survival (PFS) (P=0.007 and P=0.004, respectively). In a multivariate analysis adjusted for age, homologous recombination mutation status and increased copy number variants were independently associated with improved PFS (P=0.008 and P=0.005, respectively). These findings underscore the potential significance of variant morphologic patterns and comprehensive genomic analysis in high-grade serous carcinomas with potential implications for pathogenesis, as well as response to targeted therapies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Biomarcadores Tumorais / Neoplasias Císticas, Mucinosas e Serosas / Neoplasias das Tubas Uterinas / Ductos Paramesonéfricos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Biomarcadores Tumorais / Neoplasias Císticas, Mucinosas e Serosas / Neoplasias das Tubas Uterinas / Ductos Paramesonéfricos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos